Guangzhou LBP Medicine Science & Technology (688393.SH): Net profit for the year 2024 was 22.0369 million yuan, a year-on-year decrease of 44.99%.
Anbipelang (688393.SH) released its 2024 annual performance report announcement, reporting that the company achieved operating income...
Guangzhou LBP Medicine Science & Technology (688393.SH) released the performance report for the year 2024, during which the company achieved operating income of 471 million yuan, a decrease of 5.33% compared to the previous year; the net profit attributable to shareholders of the listed company was 22.0369 million yuan, a decrease of 44.99% year-on-year; the net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 13.7024 million yuan, a decrease of 61.20% year-on-year; and the basic earnings per share was 0.24 yuan/share.
Related Articles

Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families

Hims & Hers Health (HIMS.US) launches cheap weight loss pills, FDA stops sales the next day, stock price plummets after hours.

HK Bull/Bear Outstanding Qty Ratio(76:24) | February 7th
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families

Hims & Hers Health (HIMS.US) launches cheap weight loss pills, FDA stops sales the next day, stock price plummets after hours.

HK Bull/Bear Outstanding Qty Ratio(76:24) | February 7th






